{"id":"W6981310148","doi":"","title":"DREAMM-4: evaluating safety and clinical activity of belantamab mafodotin (belamaf) in combination with pembrolizumab in patients with relapsed/refractory multiple myeloma: Session: Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"PAGEPress (PAGEPress (Italy))","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Pembrolizumab; Adverse effect; Multiple myeloma; Interim analysis; Safety profile; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001147185,0.0004160498,0.001246962,0.0003114098,0.000187762,0.0000911423,0.0004029874,0.000224275,0.000281156],"category_scores_gemma":[0.0008146889,0.0004018901,0.0001208875,0.000459401,0.0003723392,0.0009029142,0.0004459604,0.0005485736,0.0001105177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001576103,"about_ca_system_score_gemma":0.00004552413,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004651108,"about_ca_topic_score_gemma":0.0002760595,"domain_scores_codex":[0.9963755,0.0001764928,0.001365766,0.001318413,0.0002134495,0.0005503478],"domain_scores_gemma":[0.9973511,0.000726874,0.001061332,0.000549106,0.0001095708,0.0002020259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003266293,0.0008991561,0.9856988,0.0001203185,0.0001464023,0.00001564338,0.001862136,0.001154269,0.00002290618,0.0002543827,0.0002362004,0.006323455],"study_design_scores_gemma":[0.01892165,0.0006340368,0.9513239,0.0001703466,0.00003615446,0.00000116441,0.0004936192,0.02724596,0.0001103698,0.00007523156,0.0004803661,0.0005071649],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899684,0.0003911619,0.0004333005,0.0001409488,0.000359457,0.0009545674,0.000525496,0.00004874751,0.007177903],"genre_scores_gemma":[0.9983553,0.0001461682,0.000588352,0.00005671918,0.00004553302,0.0000470122,0.00007111933,0.00005256441,0.0006372479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0343749,"threshold_uncertainty_score":0.9998433,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04391471674687396,"score_gpt":0.2496703058719302,"score_spread":0.2057555891250563,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}